These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12857042)

  • 21. Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy.
    Hoshikawa E; Matsumura Y; Kubo T; Okawa M; Yamasaki N; Kitaoka H; Furuno T; Takata J; Doi YL
    Am J Cardiol; 2011 Apr; 107(7):1065-70. PubMed ID: 21296328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drugs for left ventricular remodeling in heart failure.
    Frigerio M; Roubina E
    Am J Cardiol; 2005 Dec; 96(12A):10L-18L. PubMed ID: 16399088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
    Poulsen SH
    Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What constitutes optimal neurohumoral antagonism in chronic heart failure?
    Tajik AA; Dickstein K
    Heart; 2016 Dec; 102(23):1922-1932. PubMed ID: 27742799
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacological left ventricular reverse remodeling in elderly patients receiving optimal therapy for chronic heart failure.
    Cioffi G; Tarantini L; De Feo S; Pulignano G; Del Sindaco D; Stefenelli C; Opasich C
    Eur J Heart Fail; 2005 Oct; 7(6):1040-8. PubMed ID: 16227142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relation between left ventricular remodeling and clinical outcomes in heart failure patients with left ventricular systolic dysfunction.
    Udelson JE; Konstam MA
    J Card Fail; 2002 Dec; 8(6 Suppl):S465-71. PubMed ID: 12555159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of remodeling in congestive heart failure due to myocardial infarction by blockade of the renin-angiotensin system.
    Guo X; Saini HK; Wang J; Gupta SK; Goyal RK; Dhalla NS
    Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):717-32. PubMed ID: 16076281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nitric oxide's role in heart failure: pathophysiology and treatment. Introduction.
    Cohn JN; Loscalzo J; Franciosa JA
    J Card Fail; 2003 Oct; 9(5 Suppl Nitric Oxide):S197-8. PubMed ID: 14653276
    [No Abstract]   [Full Text] [Related]  

  • 29. Myocardial recovery and the failing heart: medical, device and mechanical methods.
    Goldfinger JZ; Nair AP
    Ann Glob Health; 2014; 80(1):55-60. PubMed ID: 24751565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac remodeling in coronary artery disease.
    Sharpe N
    Am J Cardiol; 2004 May; 93(9A):17B-20B. PubMed ID: 15144932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ventricular remodeling in heart failure and the effect of beta-blockade.
    Udelson JE
    Am J Cardiol; 2004 May; 93(9A):43B-8B. PubMed ID: 15144937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aldosterone receptor antagonists induce favorable cardiac remodeling in diastolic heart failure patients.
    Orea-Tejeda A; Colín-Ramírez E; Castillo-Martínez L; Asensio-Lafuente E; Corzo-León D; González-Toledo R; Rebollar-González V; Narváez-David R; Dorantes-García J
    Rev Invest Clin; 2007; 59(2):103-7. PubMed ID: 17633796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of humoral factors on left ventricular remodeling under chronic heart failure].
    Kodama M; Tachikawa H; Kashimura T; Hayashi M; Yoshida T; Hanawa H; Aizawa Y; Nakazawa M; Watanabe K
    Nihon Yakurigaku Zasshi; 2004 Feb; 123(2):63-70. PubMed ID: 14745125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of angiotensin converting enzyme inhibitors on remodeling in clinical trials.
    Greenberg BH
    J Card Fail; 2002 Dec; 8(6 Suppl):S486-90. PubMed ID: 12555162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feasibility of arresting the process of remodeling.
    Somasundaram PE; Chandrashekhar Y
    Med Clin North Am; 2004 Sep; 88(5):1193-207, x. PubMed ID: 15331313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of various proteases in cardiac remodeling and progression of heart failure.
    Müller AL; Dhalla NS
    Heart Fail Rev; 2012 May; 17(3):395-409. PubMed ID: 21739365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of carvedilol on left ventricular remodeling and systolic function in elderly patients with heart failure.
    Palazzuoli A; Bruni F; Puccetti L; Pastorelli M; Angori P; Pasqui AL; Auteri A
    Eur J Heart Fail; 2002 Dec; 4(6):765-70. PubMed ID: 12453548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacological therapeutics based on molecular mechanisms].
    Akazawa H; Komuro I
    Nihon Rinsho; 2006 May; 64(5):897-903. PubMed ID: 16689371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenesis and treatment of cardiomyopathy.
    Fonarow GC
    Adv Intern Med; 2001; 47():1-45. PubMed ID: 11795071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kinin B1 receptor blockade and ACE inhibition attenuate cardiac postinfarction remodeling and heart failure in rats.
    Lin X; Bernloehr C; Hildebrandt T; Stadler FJ; Doods H; Wu D
    Toxicol Appl Pharmacol; 2016 Aug; 305():153-160. PubMed ID: 27288733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.